Urinary tract infection in neurogenic bladder.
The most frequent medical complication in patients with neurogenic bladder dysfunction is urinary tract infection (UTI). In the acute phase of neurogenic bladder, aseptic intermittent catheterization should be applied. After this phase, patients are subject to UTIs leading to febrile diseases. In the chronic phase of neurogenic bladders, febrile infections are often accompanied with hypertonic bladder. Some causes or symptoms prior to febrile attack are recognized in many of the cases. Antimicrobial chemotherapy has to be started in time without delay. Newer generation cephalosporins and carbapenems may shorten the febrile period. We report our experience with 229 patients treated between January 1993 and December 1998.
Matsumoto
T
T
Department of Urology, University of Occupational and Environmental Health Japan, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807, Japan.
Takahashi
K
K
Manabe
N
N
Iwatsubo
E
E
Kawakami
Y
Y
D000208:Acute Disease; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D015780:Carbapenems / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002908:Chronic Disease; D004823:Epididymitis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D005260:Female; D005334:Fever / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D011472:Prostatitis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D011704:Pyelonephritis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D001743:Urinary Bladder / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D001750:Urinary Bladder, Neurogenic / Q000150:complications* / Q000188:drug therapy; D014546:Urinary Catheterization / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology* / Q000473:pathology
D000892:Anti-Infective Agents, Urinary; D015780:Carbapenems; D002511:Cephalosporins